GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Birc5 | decreases expression | EXP | | 6480464 | CTD | bisphenol A results in decreased expression of BIRC5 mRNA | PMID:25181051 | Birc5 | increases expression | EXP | | 6480464 | CTD | bisphenol A results in increased expression of BIRC5 mRNA | PMID:18180321 PMID:32145629 | Birc5 | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | CTD | bisphenol A affects the expression of BIRC5 mRNA | PMID:21826169 PMID:30903817 | Birc5 | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | CTD | bisphenol A analog results in decreased expression of BIRC5 mRNA; bisphenol A results in decreased expression of BIRC5 mRNA | PMID:27979917 PMID:29275510 PMID:32387340 PMID:33670352 PMID:36982678 | Birc5 | increases expression | ISO | Birc5 (Mus musculus) | 6480464 | CTD | bisphenol A results in increased expression of BIRC5 mRNA | PMID:27623287 | Birc5 | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | CTD | bisphenol A results in increased expression of BIRC5 mRNA; bisphenol A results in increased expression of BIRC5 protein | PMID:16474171 PMID:19270784 PMID:33312107 | Birc5 | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | CTD | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BIRC5 mRNA; [naringenin co-treated with bisphenol A] results in increased expression of BIRC5 mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of BIRC5 mRNA | PMID:28628672 PMID:36235125 | |
Go Back to source page | Continue to Ontology report |